Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/a-treatise-on-topical-corticosteroids-in-dermatology-topical-Gl3TZgA8Ae
References (28)
-
I. Beitins, I. Beitins, F. Bayard, F. Bayard, I. Ances, I. Ances, A. Kowarski, A. Kowarski, C. Migeon, C. Migeon (1972)
The transplacental passage of prednisone and prednisolone in pregnancy near term.The Journal of pediatrics, 81 5
-
R. Gitau, N. Fisk, J. Teixeira, A. Cameron, V. Glover (2001)
Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses.The Journal of clinical endocrinology and metabolism, 86 1
-
J. Seckl, M. Cleasby, M. Nyirenda (2000)
Glucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programmingKidney International, 57
-
M. Edwards, K. Agho, J. Attia, P. Diaz, T. Hayes, Alice Illingworth, L. Roddick (2003)
Case‐control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancyAmerican Journal of Medical Genetics Part A, 120A
-
P. Ballard, E. Hearney, M. Smith (1977)
Comparative teratogenicity of selected glucocorticoids applied ocularly in mice.Teratology, 16 2
-
R. Deitch (1981)
After the Trial at LeicesterThe Lancet, 318
-
D. Warrell, R. Taylor (1968)
Outcome for the foetus of mothers receiving prednisolone during pregnancy.Lancet, 1 7534
-
M. Turpeinen (1989)
Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitisEuropean Journal of Pediatrics, 148
-
Shi Wen, K. Demissie, Shiliang Liu (2001)
Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population.Annals of epidemiology, 11 1
-
K. Sun, Kaiping Yang, J. Challis, J. Challis (1998)
Glucocorticoid actions and metabolism in pregnancy: implications for placental function and fetal cardiovascular activity.Placenta, 19 5-6
-
C. Chi, G. Kirtschig, W. Aberer, J. Gabbud, J. Lipozenčić, S. Kárpáti, U. Haustein, T. Zuberbier, F. Wojnarowska (2011)
Evidence‐based (S3) guideline on topical corticosteroids in pregnancyBritish Journal of Dermatology, 165
-
J. Harris, I. Ross (1956)
Cortisone therapy in early pregnancy: relation to cleft palate.Lancet, 270 6931
-
N. Miller, C. Williamson, N. Fisk, V. Glover (2004)
Infant cortisol response after prolonged antenatal prednisolone treatmentBJOG: An International Journal of Obstetrics & Gynaecology, 111
-
Sadie Walsh, F. Clark (1967)
Pregnancy in Patients on Long-Term Corticosteroid TherapyScottish Medical Journal, 12
-
V. Murphy, R. Fittock, P. Zarzycki, M. Delahunty, R. Smith, V. Clifton (2007)
Metabolism of synthetic steroids by the human placenta.Placenta, 28 1
-
Ching-Chi Chi, Shu-Hui Wang, Richard Mayon-White, F. Wojnarowska (2013)
Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study.JAMA dermatology, 149 11
-
C. Chi, Shu-hui Wang, G. Kirtschig, F. Wojnarowska (2010)
Systematic review of the safety of topical corticosteroids in pregnancy.Journal of the American Academy of Dermatology, 62 4
-
C. Chi, R. Mayon-White, F. Wojnarowska (2011)
Safety of topical corticosteroids in pregnancy: a population-based cohort study.The Journal of investigative dermatology, 131 4
-
D. Mattison (1990)
Transdermal drug absorption during pregnancy.Clinical obstetrics and gynecology, 33 4
-
B. Murphy, S. Clark, I. Donald, M. Pinsky, D. Vedady (1974)
Conversion of maternal cortisol to cortisone during placental transfer to the human fetus.American journal of obstetrics and gynecology, 118 4
-
R. Gitau, A. Cameron, N. Fisk, V. Glover (1998)
Fetal exposure to maternal cortisolThe Lancet, 352
-
B. Källén (2003)
Maternal Drug Use and Infant Cleft Lip/Palate with Special Reference to CorticoidsThe Cleft Palate-Craniofacial Journal, 40
-
A. Kecskés, D. Heger-Mahn, R. Kuhlmann, L. Lange (1993)
Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.Journal of the American Academy of Dermatology, 29 4
-
Yves Pirson, M. Vanlierde, J. Ghysen, Jean-Paul Squifflet, G. Alexandre, C. Strihou (1985)
Retardation of fetal growth in patients receiving immunosuppressive therapy.The New England journal of medicine, 313 5
-
A. Mahé, J. Perret, F. Ly, F. Fall, J. Rault, A. Dumont (2007)
The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice.Transactions of the Royal Society of Tropical Medicine and Hygiene, 101 2
-
M. Sulzberger, V. Witten (1952)
The effect of topically applied compound F in selected dermatoses.The Journal of investigative dermatology, 19 2
-
E. Tschen, A. Bucko (1998)
Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or EczemaClinical Drug Investigation, 16
-
A. Kraus (1975)
Congenital Cataract and Maternal Steroid IngestionJournal of Pediatric Ophthalmology & Strabismus, 12
- Publisher
- Springer Singapore
- Copyright
- © Springer Nature Singapore Pte Ltd. 2018
- ISBN
- 978-981-10-4608-7
- Pages
- 81 –86
- DOI
- 10.1007/978-981-10-4609-4_6
- Publisher site
- See Chapter on Publisher Site
Abstract
[The systemic availability of topical corticosteroids alters during pregnancy due to alterations in the cutaneous hydration and blood flow. Topical corticosteroids are commonly used to treat cutaneous manifestation associated with inflammatory conditions, autoimmune response as well as dermatoses associated with atopy such as atopic dermatitis, contact dermatitis, psoriasis and lichen planus. During the first trimester of pregnancy as per existing data the safety of corticosteroids is difficult to interpret and often conflicting. Due to concerns for possible fetal harm, the pregnant women sometimes get under treated because of ‘steroid phobia’.]
Published: May 18, 2017
Keywords: Topical corticosteroids; Orofacial cleft; Fetal growth restriction